|
Product complaint#: (b)(4).Date sent to the fda: 12/2/2025.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.A manufacturing record evaluation was performed for the finished device lot, and no non-conformance's were identified.Additional information was requested; the following was obtained: when were the needles detached/pulled off from the sutures (in the package, during removal from package, during handling prior to use on patient or during use on the patient)? please specify.Received information as following from sales rep via phone today.Please refer to the event description, other information requested is unknown.H3 investigational summary: the product was returned to ethicon for evaluation.One detached needle and one suture piece outside its packaging were received for analysis.Product code vcp493h.During visual inspection of the detached needle, the swage and attachment area were noted to be as expected, and the barrel hole was examined under magnification with remnant suture noted.The suture end was noted to be cut at the swage area, attributed to a clip off defect.No patient or user-related adverse outcomes were reported in the investigation summary.Based on the information currently available, a product issue was identified during the investigation of the sample received.This product issue will be addressed through eth quality system.Additional complaint information monitoring for potential safety signals is conducted through complaint trending as part of post market surveillance.
|